These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24214411)

  • 21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer.
    He WZ; Hu WM; Wang F; Rong YM; Yang L; Xie QK; Yang YZ; Jiang C; Qiu HJ; Lu JB; Zhang B; Ding PR; Xia XJ; Shao JY; Xia LP
    J Natl Compr Canc Netw; 2019 Oct; 17(10):1174-1183. PubMed ID: 31590148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
    Franko J; Shi Q; Meyers JP; Maughan TS; Adams RA; Seymour MT; Saltz L; Punt CJA; Koopman M; Tournigand C; Tebbutt NC; Diaz-Rubio E; Souglakos J; Falcone A; Chibaudel B; Heinemann V; Moen J; De Gramont A; Sargent DJ; Grothey A;
    Lancet Oncol; 2016 Dec; 17(12):1709-1719. PubMed ID: 27743922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic Sites in Rare Genitourinary Malignancies and Primary Cancer Sites in Genitourinary Organ Metastases: A Secondary Analysis Using the Japanese Pathological Autopsy Registry Database.
    Oka S; Hara T; Ito S; Hayashida M; Sakaguchi K; Urakami S
    Eur Urol Open Sci; 2024 Jan; 59():78-89. PubMed ID: 38298769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.
    Zhang L; Zhang S; Yao J; Lowery FJ; Zhang Q; Huang WC; Li P; Li M; Wang X; Zhang C; Wang H; Ellis K; Cheerathodi M; McCarty JH; Palmieri D; Saunus J; Lakhani S; Huang S; Sahin AA; Aldape KD; Steeg PS; Yu D
    Nature; 2015 Nov; 527(7576):100-104. PubMed ID: 26479035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
    Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
    Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastasis: inherent vs. acquired phenotype.
    Zhang LJ; Li H; Zhang LY; Gu Y; Song Y; Li F; Jiang LN; Li Q; Zhang HZ; Zhang F
    Med Hypotheses; 2010 May; 74(5):874-6. PubMed ID: 20006450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids.
    Johnson CH; Santidrian AF; LeBoeuf SE; Kurczy ME; Rattray NJW; Rattray Z; Warth B; Ritland M; Hoang LT; Loriot C; Higa J; Hansen JE; Felding BH; Siuzdak G
    Cancer Metab; 2017; 5():9. PubMed ID: 29093815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis.
    Jin X; Zhu Z; Shi Y
    Bull Cancer; 2014 Oct; ():. PubMed ID: 25296411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies.
    Yin L; Li J; Ma D; Li D; Sun Y
    Oncol Lett; 2020 May; 19(5):3558-3566. PubMed ID: 32269630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
    Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
    Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Unique trend" and "contradictory trend" in discrimination of primary synchronous lung cancer and metastatic lung cancer.
    Shen C; Xu H; Liu L; Zhou Y; Chen D; Du H; Han Z; Che G
    BMC Cancer; 2013 Oct; 13():467. PubMed ID: 24106770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
    Lee WC; Reuben A; Hu X; McGranahan N; Chen R; Jalali A; Negrao MV; Hubert SM; Tang C; Wu CC; Lucas AS; Roh W; Suda K; Kim J; Tan AC; Peng DH; Lu W; Tang X; Chow CW; Fujimoto J; Behrens C; Kalhor N; Fukumura K; Coyle M; Thornton R; Gumbs C; Li J; Wu CJ; Little L; Roarty E; Song X; Lee JJ; Sulman EP; Rao G; Swisher S; Diao L; Wang J; Heymach JV; Huse JT; Scheet P; Wistuba II; Gibbons DL; Futreal PA; Zhang J; Gomez D; Zhang J
    Genome Biol; 2020 Nov; 21(1):271. PubMed ID: 33148332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade.
    Abdel Sater AH; Bouferraa Y; Amhaz G; Haibe Y; Lakkiss AE; Shamseddine A
    Front Oncol; 2022; 12():804983. PubMed ID: 35600385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of myeloid-derived suppressor cells in tumor recurrence.
    Cole K; Al-Kadhimi Z; Talmadge JE
    Cancer Metastasis Rev; 2023 Mar; 42(1):113-142. PubMed ID: 36640224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
    Singhi AD; Cimino-Mathews A; Jenkins RB; Lan F; Fink SR; Nassar H; Vang R; Fetting JH; Hicks J; Sukumar S; De Marzo AM; Argani P
    Mod Pathol; 2012 Mar; 25(3):378-87. PubMed ID: 22056952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.